Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DC-20-001 from the NIH Guide for Grants and Contracts. The over-arching goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical research and its implications in the areas of auditory and vestibular research. The complexity of auditory and vestibular biology processes provide our hearing and balance function. Interruption of these processes may occur from a variety of factors, including genetic, environmental and pathogenic agents, and often results in the loss of hearing and balance function. While loss or impairment of these functions ar...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 23, 2020 Category: Research Source Type: funding

Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
The NIH Office of Laboratory Animal Welfare (OLAW) is deeply concerned about the impact of the expanding outbreak of the respiratory illness, COVID-19, on the ability of Assured institutions to support the well-being of animals and personnel during this public health emergency. See NOT-OD-20-088 for flexibilities provided in the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (Policy) that are applicable to implementing a pandemic plan for animal care and use programs.  (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - March 17, 2020 Category: Research Authors: NIH Staff Tags: Policy Top Stories Source Type: funding

NSF Innovation Corps Hubs Program (I-CorpsTM Hubs)
Full Proposal Deadline Date: April 14, 2020 Program Guidelines: NSF 20-529The National Science Foundation (NSF) seeks to further develop and nurture a national innovation ecosystem that guides the output of scientific discoveries closer to the development of technologies, products, and services that benefit society. The goal of the NSF Innovation Corps (I-Corps) Program, created in 2011 by NSF, has been and will continue to be to reduce the time and risk associated with translating promising ideas and technologies from the laboratory to the ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505760&WT.mc_id=USN...
Source: NSF Upcoming Due Dates - March 15, 2020 Category: Science Source Type: funding

Rural Experiences for Health Professions Students Summer Experience Program
A program that places clinical psychology, master of social work, physician, physician assistant, medical laboratory science, nurse practitioner, pharmacy, nursing, physical and occupational therapy students from South Dakota in a 4-week experience with preceptors established in rural or frontier areas of South Dakota. Geographic coverage: South Dakota -- Yankton Rural Area Health Education Center (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 2, 2020 Category: American Health Source Type: funding

Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
Funding Opportunity PAR-20-117 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) under this FOA is a grant to provide support for a program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is a collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this FOA will: Enable investigators to apply earlier in their independent research careers, allow...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 24, 2020 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments
Notice NOT-GM-20-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2020 Category: Research Source Type: funding

Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
Funding Opportunity RFA-OD-20-002 from the NIH Guide for Grants and Contracts. This FOA encourages grant applications for national Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, and national basis. The important mission of the projects described by this FOA is to provide research resources, which are facilitating the optimization an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding

Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed)
The objectives are to identify the multiple factors involved, the multiple cell types involved and the mechanisms underlying rejuvenation or accelerated aging that is observed in the transfer of phenotypes between young and old laboratory animals. It is also anticipated that molecular signatures of rejuvenation or accelerated aging will be obtained from research supported under this FOA. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2019 Category: Research Source Type: funding

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-074 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 10, 2019 Category: Research Source Type: funding

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
Funding Opportunity RFA-HD-21-012 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive health through research excellence and innovation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding

New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that can better reflect the variability in human populations in chemical toxicity testing. Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically relevant toxic...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding

Reminder: Annual Reports to the Office of Laboratory Animal Welfare due January 31, 2020
Notice NOT-OD-20-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2019 Category: Research Source Type: funding

Limited Competition: Competitive Supplement to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-19-506 from the NIH Guide for Grants and Contracts. Type 1 diabetes (T1D) is a serious and burdensome chronic disease that usually onsets in childhood or early adulthood. Recent progress in clinical trials and understanding of T1D pathogenesis and mechanisms have created opportunities to delay the onset and progression of the disease. This supplement is intended to provide resources for the design and conduct of new intervention studies in individuals at early pre-clinical stages of T1D and in individuals with new-onset T1D through the T1D TrialNet network (TrialNet). This Funding Opportunity An...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2019 Category: Research Source Type: funding

Limited Competition: Competitive Supplement to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Type 1 diabetes (T1D) is a serious and burdensome chronic disease that usually onsets in childhood or early adulthood. Recent progress in clinical trials and understanding of T1D pathogenesis and mechanisms have created opportunities to delay the onset and progression of the disease. This supplement is intended to provide resources for the design and conduct of new intervention studies in individuals at early pre-clinical stages of T1D and in individuals with new-onset T1D through the T1D TrialNet network (TrialNet). This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Inve...
Source: NIDDK Funding Opportunities - November 14, 2019 Category: Endocrinology Source Type: funding

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Funding Opportunity PAR-20-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 4, 2019 Category: Research Source Type: funding

NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-021 from the NIH Guide for Grants and Contracts. (Reissue of PAR-16-458) The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in postdoctoral position. Based on the early timeframe of eligibility, and the discouragement of inclusion of preliminary data, this NINDS F32 seeks to foster early, goal-directed planning and to encourage applicatio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 18, 2019 Category: Research Source Type: funding

Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)
Funding Opportunity PAR-20-035 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is supported by Collaborative Research on Addiction (CRAN) at the National Institutes of Health (NIH), a trans-NIH partnership composed of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI). The intent of this FOA is two-fold: (1) characterize how the neurobiological alterations, associated behaviors, and public health consequences arising from polysubstance use differ from, or are similar to, those observed...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 18, 2019 Category: Research Source Type: funding

Final Report on Reducing Administrative Burdens Associated with Research Involving Laboratory Animals
This report, called for in the 21st Century Cures Act, is the culmination of more than two years of diligent work to address inconsistent and overlapping policies governing oversight of research involving animals, while ensuring research findings remain credible and research institutions safeguard animal welfare.  Regulations and policies overseeing federally-sponsored research help ensure NIH remains a responsible steward of public funds. This extends to properly enforcing the public’s expectation on how laboratory animals will be used in biomedical research, teaching, and testing. Many stakeholders have po...
Source: NIH Extramural Nexus - September 25, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Administrative Burden Animal Welfare Source Type: funding

Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required)
Funding Opportunity RFA-CA-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This Limited-Competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 23, 2019 Category: Research Source Type: funding

Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
Funding Opportunity RFA-OD-19-027 from the NIH Guide for Grants and Contracts. The Office of Research Infrastructure Programs (ORIP) encourages grant applications aimed at developing, characterizing or improving animal models of human diseases; improving access to information about or generated from the use of animal models of human disease; or improving diagnosis and control of diseases of laboratory animals. The animal models and related materials developed must have broad application to multiple NIH Institutes or Centers (ICs) to align with the ORIPs trans-NIH mission. Applications must describe the need and potential ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2019 Category: Research Source Type: funding

Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
Funding Opportunity PAR-19-367 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) provides support for the program of research in an investigator's laboratory that is within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this program will: Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively; Increase flexibility for investigators to follow important new research directions w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 9, 2019 Category: Research Source Type: funding

Thoughts on How Institutions Can Promote a Culture of Research Integrity
On May 22, I had the privilege of participating in a terrific national conference that focused on what institutions can do to foster a culture of research integrity (see the agenda here).  The DHHS Office of Research Integrity (ORI), Northwestern University, and the Council of Graduate Schools hosted the conference, “The Role of Research Integrity in Promoting Excellence: Tools for Colleges and University Leaders.”  The conference organizers’ goal was “to engage university and college leaders in lively discussions about strategies, resources, and tools for promoting research integrity for ...
Source: NIH Extramural Nexus - August 15, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Research integrity Source Type: funding

Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-055 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support the development of technology, tools that will facilitate, accelerate, and/or enhance research using advanced human-derived next generation cancer models, such as organoids, conditionally reprogrammed cells, and others. The studies proposed under this FOA must focus entirely on the next generation cancer models developed under the auspices of an international consortium with NCI participation, Human Cancer Models Initiative. "Technology to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2019 Category: Research Source Type: funding

Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-007 from the NIH Guide for Grants and Contracts. The primary aim of this Funding Opportunity Announcement (FOA) is to facilitate the characterization of the marmoset as a laboratory animal for research on aging and age-related diseases. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2019 Category: Research Source Type: funding

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-291 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 5, 2019 Category: Research Source Type: funding

Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Funding Opportunity PAR-19-286 from the NIH Guide for Grants and Contracts. The NIGMS Postdoctoral Research Associate Training (PRAT) Programs overarching goal is to provide high quality postdoctoral research training in the basic biomedical sciences to a diverse group of postdoctoral fellows in NIH Intramural research laboratories, and to prepare them for leadership positions in biomedical careers. Research projects proposed should focus on areas within the NIGMS mission, which include but are not limited to biological chemistry, biophysics, bioinformatics, cellular and molecular biology, computational biosciences, devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 21, 2019 Category: Research Source Type: funding

Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
Funding Opportunity PAR-19-285 from the NIH Guide for Grants and Contracts. The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research on the evolving HIV epidemic in their countries. This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 14, 2019 Category: Research Source Type: funding

Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-265 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR)projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the design, implementation, and creation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2019 Category: Research Source Type: funding

Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-266 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Technology Transfer (STTR) projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the design, implementation, and creation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2019 Category: Research Source Type: funding

HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-19-045 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Clinical Trials Units (CTUs) to provide scientific and administrative expertise as well as the infrastructure to conduct clinical studies developed by NIH HIV/AIDS Clinical Trials Networks. Clinical Trials Units will participate in the development of trials and provide clinical sites, local laboratory capacity, and pharmacy support for two or more HIV/AIDS Clinical Trials Networks. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 1, 2019 Category: Research Source Type: funding

Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-249 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research to explore the impacts of extreme weather and disaster events on the basic biology of aging. The goal is to fund studies in laboratory animals that will complement and inform studies in the companion FOA on the adverse effects of extreme weather and related disasters in the elderly and adults over the aging life course. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2019 Category: Research Source Type: funding

Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-20-014 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to fund research centers that will establish longitudinal cohorts in rare HLBS diseases to investigate unaddressed research questions using epidemiologic study designs and methods that are appropriate for conditions affecting fewer than 200,000 persons in the US. These observational cohort studies should be designed to provide an evidence base for future interventional studies, including clinical trials; for developing better diagnostics than those that are currently available; for answering early translational questi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2019 Category: Research Source Type: funding

Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed)
Funding Opportunity RFA-FD-19-018 from the NIH Guide for Grants and Contracts. The intended outcome of this cooperative agreement is to advance the goal of a national food safety system by supporting and enhancing state food laboratories tasked with investigation of foodborne disease outbreaks in activities including: 1. Ensuring microbiological and chemical food analyses performed on behalf of the State manufactured food regulatory programs are conducted within the scope of an International Organization for Standardization (ISO)/ International Electrotechnical Commission (IEC) 17025 accredited laboratory; 2. Strengthenin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2019 Category: Research Source Type: funding

New Deadline for Proposals to Collaborate with the NIH Common Fund Regenerative Medicine Programs (RMP) Stem Cell Translation Laboratory (SCTL)
Notice NOT-RM-19-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2019 Category: Research Source Type: funding

Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional)
Funding Opportunity RFA-FD-19-003 from the NIH Guide for Grants and Contracts. The Food and Drug Administration (FDA)/ Center for Food and Safety and Applied Nutrition (CFSAN) is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2019 to the Illinois Institute of Technology to support the Institute for Food Safety and Health (IFSH). The purposes of this continued support are to: 1. Carry out multidisciplinary applied research projects on the safety of processed foods; on food processing and packaging technologies; on the impact of these proc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 12, 2019 Category: Research Source Type: funding

Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-176 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports exploratory research projects aimed at developing cryogenic or other long-term preservation and revival approaches for Drosophila or zebrafish genetic stocks, which are essential laboratory animal models for biomedical research. The proposed project should address critical knowledge and technology gaps and describe approaches towards the development of reliable, easy-to-use and cost effective cryogenic or other long-term preservation and revival methods for wild-type and mutant strains of Drosop...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2019 Category: Research Source Type: funding

HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-19-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for HIV/AIDS Clinical Trials Networks Laboratory Centers (LCs). Each LC will be responsible for providing a framework for laboratory leadership, structure and activities that contribute to the development and execution of the laboratory elements of NIAID HIV/AIDS Clinical Trials Networks research agendas. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2019 Category: Research Source Type: funding

Non-human Primates Facilities to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-114 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites qualified research institution to seek funds to modernize existing research facilities that focus on HIV/AIDS-related research. Institutions that support non-human primate colonies are encouraged to apply to update the animal housing infrastructure and research-dedicated space needed for the animal-related research efforts. Any request must be justified by the needs of NIH-funded investigators who used the laboratory space or rely on the animals raised and care for by the facilities. Applications...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2018 Category: Research Source Type: funding

NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-19-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) to establish 5 new awards for the Research Evaluation and Commercialization Hubs (REACH) program to address the problems that hinder the critical, early steps necessary to translate novel scientific advances and discoveries into commercially viable diagnostics, devices, therapeutics, and tools that improve patient care and advance public health. The five awardees will participate in a technology development consortium that incorporates best pract...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2018 Category: Research Source Type: funding

NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) to establish 5 new awards for the Research Evaluation and Commercialization Hubs (REACH) program to address the problems that hinder the critical, early steps necessary to translate novel scientific advances and discoveries into commercially viable diagnostics, devices, therapeutics, and tools that improve patient care and advance public health. The five awardees will participate in a technology development consortium that incorporates best practices from current pilot programs and fulfills the objectives of the Phase 0 Proo...
Source: NIDDK Funding Opportunities - December 17, 2018 Category: Endocrinology Source Type: funding

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
Funding Opportunity PAR-19-100 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from two or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 12, 2018 Category: Research Source Type: funding

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-099 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from three or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaboratio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 12, 2018 Category: Research Source Type: funding

Comments Welcomed on the Draft Report Recommending How to Reduce Administrative Burden in Research with Laboratory Animals: A Next Step in Implementing the 21st Century Cures Act
The 21st Century Cures Act requires federal agencies to “review applicable regulations and policies for the care and use of laboratory animals and make revisions, as appropriate, to reduce administrative burden on investigators while maintaining the integrity and credibility of research finding and protection of research animals.” This past March we requested feedback from the public on ways to reduce regulatory burden while also maintaining the highest standards for protecting animal welfare and scientific integrity. You responded with constructive and helpful feedback with more than 19,000 comments. Generally...
Source: NIH Extramural Nexus - December 7, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Administrative Burden Animal Welfare Request For Information (RFI) Source Type: funding

Reminder: Annual Reports to the Office of Laboratory Animal Welfare due January 31, 2019
Notice NOT-OD-19-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2018 Category: Research Source Type: funding

Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional)
Funding Opportunity RFA-AA-19-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement applications for research that advances promising compounds thorough the drug development pipeline for the treatment of Alcohol Use Disorder (AUD). NIAAA is seeking applications for medications development research projects from both for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, small businesses not eligible for the SBIR/STTR program and single entiti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

Working Together to Protect the Integrity of NIH-funded Research
When research findings are made up from thin air, misrepresented in some way, or blatantly and without credit copied from others, we risk eroding the public’s trust, damaging institutional reputation, harming careers, incurring skepticism, misleading future research, and, arguably most importantly, hurting patients. NIH takes research misconduct seriously. We are being proactive. A recently published Notice reminds the community about our expectations that NIH-supported institutions address misconduct allegations when they occur (see NOT-OD-19-020). When a recipient institution finds, learns of, or suspects research ...
Source: NIH Extramural Nexus - November 15, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Research integrity research misconduct Source Type: funding

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-040 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the optimization of small molecule or biologic compounds that are excellent candidates for therapeutic development. The mission of the CounterACT Program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released fro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2018 Category: Research Source Type: funding

Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-930 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support the development and optimization of tasks and measures for constructs pertaining to functional aspects of behavior, for use in laboratory or population-based studies. This announcement encourages research that will result in the availability of tasks and measures that demonstrate: (1) good validity as a measure of a specific construct; (2) robust measurement properties; and (3) suitability for use across diverse participants. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

WINDOWS ON THE UNIVERSE: THE ERA OF MULTI-MESSENGER ASTROPHYSICS (WoU-MMA)
Full Proposal Deadline Date: October 19, 2018 Plasma Physics Program Guidelines: PD 18-5115The universe is the ultimate laboratory, and we can now probe it as never before through several powerful and diverse windows – electromagnetic waves, high-energy particles, and gravitational waves.  Each of these windows provides a different view.  Together they reveal a detailed picture of the Universe that will allow us to study matter, energy, and the cosmos in fundamentally new ways. The NSF's Big Idea “Windows on the Universe” is implemented through ...More at https://www.nsf.gov/funding/pgm_summ.js...
Source: NSF Upcoming Due Dates - September 19, 2018 Category: Science Source Type: funding

Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)
Funding Opportunity PA-18-926 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support eligible postdoctoral scientists maintain high productivity in an NIAID-funded laboratory while engaging in primary caregiver responsibilities. This program will provide administrative supplements to existing NIAID research grants to hire a full-time or part-time laboratory technician to work with the postdoctoral scientist on their project. Administrative supplements must support work within the scope of the original project. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2018 Category: Research Source Type: funding